# SITAGLIPTIN AND METFORMIN HCL
> **ANDA218971** · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA LTD · Approved 2024-12-11
## Drug
- **FDA Application Number:** ANDA218971
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN AND METFORMIN HCL
- **Generic name:** Sitagliptin, Metformin Hydrochloride
- **Active ingredients:** SITAGLIPTIN, METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MANKIND PHARMA LTD
- **First approval:** 2024-12-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218971)
---
*AI Analytics · CC0 1.0*